CDC. CDC guidelines for large-scale influenza vaccination clinic planning. Aug 4, 2010 [Full text]

CDC. Destruction of influenza A (H2N2) proficiency testing samples; interim guidance for biosafety level 3-enhanced biocontainment for work with human influenza A (H2N2) viruses. May 3, 2005 [Full text]

CDC. Interim guidance for the use of masks to control influenza transmission. Aug 1, 2009 [Full text]

FDA. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. Released Mar 2, 2010 [Full text]

FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. May 31, 2007 [Full text]

IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007 [Full text]

NICE (UK National Institute for Health and Clinical Excellence). Influenza (prophylaxis): amantadine, oseltamivir and zanamivir. Sep 24, 2008 [Full text of several guidance documents]